Effect of neoadjuvant chemotherapy on ER, PR, c-erb2, VEGF and Ki-67 in patients with locally advanced breast cancer

Sarıtaş, Ahmet; Yalav, Orçun; Kekeç, Yalçın; Sakman, Gürhan; Kılıç, Emine; Zorludemir, Suzan; Ergïn, Melek; Eray, İsmail Cem; Kara, Oǧuz; Paydaş, Semra

doi:10.17826/cumj.412192

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

2024

Publication Types

Select...

Other1

Article1

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 24 publications

(60 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Technical Review of Breast Cancer Screening and Detection using Artificial Intelligence and Radiomics

Singh,

Kaur,

Singh

et al. 2024

2024 11th International Conference on Computing for Sustainable Global Development (INDIACom)

View full text Add to dashboard Cite

Technical Review of Breast Cancer Screening and Detection using Artificial Intelligence and Radiomics

Singh,

Kaur,

Singh

et al. 2024

2024 11th International Conference on Computing for Sustainable Global Development (INDIACom)

View full text Add to dashboard Cite

Response of Caf Regimen as Neo-Adjuvant Chemotherapy in Downstaging Locally Advanced Breast Carcinoma

Grover

Sivarajan

Suganth

et al. 2021

Global Journal for Research Analysis

View full text Add to dashboard Cite

BACKGROUND:In India, locally advanced breast cancer (LABC) is responsible for 30 - 35% of all breast cancer cases. The purpose of preoperative chemotherapy is that it is capable of shrinking large primary tumors rendering many inoperable patients operable METHODS: 2 2 The doses of the drugs used were Cyclophosphamide - 600 mg/m IV infusion, Adriamycin - 50 mg/m IV infusion 2 and 5 uorouracil (FU) - 600 mg/m IV infusion. Clinical response was noted after 3 weeks of third cycle of NACT which was assessed according to RECIST criteria RESULTS: 78.1% of our patients responded to NACT (cCR + cPR) with pCR in 17.2% of patients. percentage of complete response was higher for patients in stage IIIA than for the patient in stage IIIB CONCLUSION: neo-adjuvant chemotherapy integrated into a multi-modality program is the standard management in patients with locally advanced breast carcinoma. The patients with pathological complete response and patients without axillary lymph node were associated with improved outcome after neo adjuvant chemo therapy

show abstract

Effect of neoadjuvant chemotherapy on ER, PR, c-erb2, VEGF and Ki-67 in patients with locally advanced breast cancer

Cited by 2 publications

References 24 publications

Technical Review of Breast Cancer Screening and Detection using Artificial Intelligence and Radiomics

Technical Review of Breast Cancer Screening and Detection using Artificial Intelligence and Radiomics

Response of Caf Regimen as Neo-Adjuvant Chemotherapy in Downstaging Locally Advanced Breast Carcinoma

Contact Info

Product

Resources

About